MTOR and gestational diabetes: At a molecular level, a further study suggested that miR-503 regulated functions of pancreatic β-cells by targeting the mammalian target of rapamycin (mTOR) pathway, suggesting that targeting the miR-503/mTOR axis could serve as a novel therapeutic target for GDM (79).